Vote!
FDA Approves Drug for Chronic Drooling in Children
The U.S. Food and Drug Administration today approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years....
Published By : FDA - Wednesday, 28 July
- Older Health Info
- Vote! F.D.A. Panel Approves Use of Antidepressant for Pain
NYT - Health Blog - Thursday, 19 August - Vote! FDA Approves New Drug for Advanced Prostate Cancer Cancer - Tuesday, 17 August
- Vote! Shionogi Inc. Announces FDA Approval Of CUVPOSA™ For The Treatment Of Chronic Severe Drooling In Pediatric Patients With Neurologic Conditions
MedicalNews - Friday, 30 July
-
-
-
-
- Vote! Cuvposa Approved for Chronic Drooling in Children Healthfinder - Thursday, 29 July
- Vote! SPRYCEL(R) (dasatinib) Receives FDA Priority Review For The Treatment Of Adult Patients With Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase
- Vote! FDA Approves New Indication for Tasigna
FDA - Thursday, 17 June